Genomictree Signs Contract to Acquire 5 Billion KRW Worth of Treasury Shares

[Asia Economy Reporter Hwang Yoon-joo] Genomictree announced on the 17th that it has signed a trust contract for the acquisition of treasury shares worth 5 billion KRW to stabilize its stock price and enhance shareholder value. The contract period is from May 17, 2022, to November 16, 2022.